Global trends and predictions in hepatocellular carcinoma mortality

Journal of Hepatology

Volumn 67, Issue 2, 2017, Pages 302-309

  Bertuccio, Paola ^a   Turati, Federica ^a   Carioli, Greta ^a   Rodriguez, Teresa ^b   La Vecchia, Carlo ^a   Malvezzi, Matteo ^a,c   Negri, Eva ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b Instituto de Investigación Sanitaria de Navarra   (Spain)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Carcinoma, hepatocellular; Mortality; Projections; Trends; Worldwide

Indexed keywords

ADULT; AGE; ARTICLE; ASIA; AUSTRALIA; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CHILE; CONTROLLED STUDY; CZECH REPUBLIC; DENMARK; EAST ASIA; FEMALE; FRANCE; GERMANY; HONG KONG; HUMAN; ISRAEL; ITALY; JAPAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEXICO; MIDDLE AGED; NETHERLANDS; NORWAY; PORTUGAL; PREDICTION; PRIORITY JOURNAL; ROMANIA; SERBIA; SEX DIFFERENCE; SOUTH KOREA; SPAIN; SWITZERLAND; TREND STUDY; UNITED KINGDOM; UNITED STATES; YOUNG ADULT; CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; COMPLICATION; GLOBAL HEALTH; LIVER TUMOR; MORTALITY; RISK FACTOR; TRENDS;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; GLOBAL HEALTH; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 85018813227     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2017.03.011     Document Type: Article

References (54)

1. Hashim, D., Boffetta, P., La Vecchia, C., Rota, M., Bertuccio, P., Malvezzi, M., et al. The global decrease in cancer mortality: trends and disparities. Ann Oncol 27 (2016), 926–933.
2. La Vecchia, C., Lucchini, F., Franceschi, S., Negri, E., Levi, F., Trends in mortality from primary liver cancer in Europe. Eur J Cancer 36 (2000), 909–915.
3. Bosetti, C., Turati, F., La Vecchia, C., Hepatocellular carcinoma epidemiology. Best Pract Res Clin Gastroenterol 28 (2014), 753–770.
4. Bosetti, C., Bertuccio, P., Malvezzi, M., Levi, F., Chatenoud, L., Negri, E., et al. Cancer mortality in Europe, 2005–2009, and an overview of trends since 1980. Ann Oncol 24 (2013), 2657–2671.
5. Bosetti, C., Levi, F., Boffetta, P., Lucchini, F., Negri, E., La Vecchia, C., Trends in mortality from hepatocellular carcinoma in Europe, 1980–2004. Hepatology 48 (2008), 137–145.
6. Stanaway, J.D., Flaxman, A.D., Naghavi, M., Fitzmaurice, C., Vos, T., Abubakar, I., et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 388 (2016), 1081–1088.
7. Turati, F., Galeone, C., Rota, M., Pelucchi, C., Negri, E., Bagnardi, V., et al. Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies. Ann Oncol 25 (2014), 1526–1535.
8. Chuang, S.C., La Vecchia, C., Boffetta, P., Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett 286 (2009), 9–14.
9. Bravi, F., Tavani, A., Bosetti, C., Boffetta, P., La Vecchia, C., Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-analysis of prospective studies. Eur J Cancer Prev, 2016 [Epub ahead of print].
10. Polesel, J., Talamini, R., Montella, M., Maso, L.D., Crovatto, M., Parpinel, M., et al. Nutrient intake and the risk of hepatocellular carcinoma in Italy. Eur J Cancer 43 (2007), 2381–2387.
11. Shivappa, N., Hebert, J.R., Polesel, J., Zucchetto, A., Crispo, A., Montella, M., et al. Inflammatory potential of diet and risk for hepatocellular cancer in a case-control study from Italy. Br J Nutr 115 (2016), 324–331.
12. Turati, F., Trichopoulos, D., Polesel, J., Bravi, F., Rossi, M., Talamini, R., et al. Mediterranean diet and hepatocellular carcinoma. J Hepatol 60 (2014), 606–611.
13. World Health Organization Statistical Information System. WHO mortality database. Geneva: World Health Organization, 2014. [Internet]. [Cited 2016 Sep 20]. Available from: http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html.
14. World Health Organization, International Classification of Disease: 9th revision. 1977, World Health Organization, Geneva.
15. World Health Organization, International Statistical Classification of Disease and related Health Problems: 10th revision. 1992, World Health Organization, Geneva.
16. Pan American Health Organization (PAHO). Health Statistics from the Americas, 2006 Edition, Chapter VI, 2-20. [Internet]. [Cited 2016 Sep 20]. Available from: http://www.paho.org/English/DD/AIS/HSA2006.htm.
17. Pan American Health Organization (PAHO). Regional Core Health Data Initiative. Table Generator System. [Internet]. [Cited 2016 Sep 20]. Available from: http://www.paho.org/English/SHA/coredata/tabulator/newTabulator.htm.
18. Doll, R., Smith, P.G., Comparison between registries: age-standardized rates. Vol. IV. IARC Sci Publ No. 42. Waterhouse, J.A.H., Muir, C.S., Shanmugaratnam, K., Powell, J., Peacham, D., Whelan, S., (eds.) Cancer incidence in five continents, 1982, IARC, Lyon, 671–675.
19. Kim, H.J., Fay, M.P., Feuer, E.J., Midthune, D.N., Permutation tests for joinpoint regression with applications to cancer rates. (Erratum. In: Stat Med 2001;20: 655). Stat Med 19 (2000), 335–351.
20. National Cancer Institute. Joinpoint Regression Program, version 4.1. [Internet]. [Cited 2015 Mar 10]. Available from: http://srab.cancer.gov/joinpoint/.
21. Clegg, L.X., Hankey, B.F., Tiwari, R., Feuer, E.J., Edwards, B.K., Estimating average annual per cent change in trend analysis. Stat Med 28 (2009), 3670–3682.
22. Faraway, Julian J., Linear Models with R. Texts in statistical science, Vol. 63., 2005, Chapman & Hall/CRC, Boca Raton.
23. US Census Bureau. 2014 National Population Projections. [Internet]. [Cited 2016 Oct 15]. Available from: http://www.census.gov/population/projections/data/national/2014.html.
24. European Commission. Eurostat population database. [Internet]. [Cited 2016 Oct 15]. Available from: http://epp.eurostat.ec.europa.eu/portal/page/portal/population/data/database.
25. Research NIoPaSS. Japanese National Institute of Population and Social Security Research. [Internet]. [Cited 2016 Oct 15]. Available from: http://www.ipss.go.jp/index-e.asp.
26. Ryerson, A.B., Eheman, C.R., Altekruse, S.F., Ward, J.W., Jemal, A., Sherman, R.L., et al. Annual Report to the Nation on the Status of Cancer, 1975–2012, featuring the increasing incidence of liver cancer. Cancer 122 (2016), 1312–1337.
27. Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., et al. Cancer statistics in China, 2015. CA Cancer J Clin 66 (2016), 115–132.
28. Turati, F., Talamini, R., Pelucchi, C., Polesel, J., Franceschi, S., Crispo, A., et al. Metabolic syndrome and hepatocellular carcinoma risk. Br J Cancer 108 (2013), 222–228.
29. Choo, S.P., Tan, W.L., Goh, B.K., Tai, W.M., Zhu, A.X., Comparison of hepatocellular carcinoma in Eastern vs. Western populations. Cancer 122 (2016), 3430–3446.
30. Jee, S.H., Ohrr, H., Sull, J.W., Samet, J.M., Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 96 (2004), 1851–1856.
31. Braga, C., La Vecchia, C., Negri, E., Franceschi, S., Attributable risks for hepatocellular carcinoma in northern Italy. Eur J Cancer 33 (1997), 629–634.
32. Franceschi, S., Montella, M., Polesel, J., La Vecchia, C., Crispo, A., Dal Maso, L., et al. Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiol Biomarkers Prev 15 (2006), 683–689.
33. Welzel, T.M., Graubard, B.I., Quraishi, S., Zeuzem, S., Davila, J.A., El-Serag, H.B., et al. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol 108 (2013), 1314–1321.
34. Fan, J.H., Wang, J.B., Jiang, Y., Xiang, W., Liang, H., Wei, W.Q., et al. Attributable causes of liver cancer mortality and incidence in china. Asian Pac J Cancer Prev 14 (2013), 7251–7256.
35. Sun, Z., Chen, T., Thorgeirsson, S.S., Zhan, Q., Chen, J., Park, J.H., et al. Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China. Carcinogenesis 34 (2013), 1800–1805.
36. Yu, S.Z., Chen, G., Zhi, X.L., Li, J., Primary liver cancer: natural toxins and prevention in China. J Toxicol Sci 23 (1998), 143–147.
37. Liu, Y., Chang, C.C., Marsh, G.M., Wu, F., Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis. Eur J Cancer 48 (2012), 2125–2136.
38. Goh, G.B., Chang, P.E., Tan, C.K., Changing epidemiology of hepatocellular carcinoma in Asia. Best Pract Res Clin Gastroenterol 29 (2015), 919–928.
39. Umemura, T., Ichijo, T., Yoshizawa, K., Tanaka, E., Kiyosawa, K., Epidemiology of hepatocellular carcinoma in Japan. J Gastroenterol 44 (2009), 102–107.
40. Njei, B., Rotman, Y., Ditah, I., Lim, J.K., Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology 61 (2015), 191–199.
41. White, D.L., Thrift, A.P., Kanwal, F., Davila, J., El-Serag, H.B., Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012. Gastroenterology, 2016.
42. El-Serag, H.B., Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127 (2004), S27–S34.
43. La Vecchia, C., Bosetti, C., Bertuccio, P., Castro, C., Pelucchi, C., Negri, E., Trends in alcohol consumption in Europe and their impact on major alcohol-related cancers. Eur J Cancer Prev 23 (2014), 319–322.
44. Giacosa, A., Barale, R., Bavaresco, L., Gatenby, P., Gerbi, V., Janssens, J., et al. Cancer prevention in Europe: the Mediterranean diet as a protective choice. Eur J Cancer Prev 22 (2013), 90–95.
45. Colombo, M., de Franchis, R., Del Ninno, E., Sangiovanni, A., De Fazio, C., Tommasini, M., et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 325 (1991), 675–680.
46. La Vecchia, C., Negri, E., Cavalieri d'Oro, L., Franceschi, S., Liver cirrhosis and the risk of primary liver cancer. Eur J Cancer Prev 7 (1998), 315–320.
47. Randi, G., Altieri, A., Gallus, S., Franceschi, S., Negri, E., Talamini, R., et al. History of cirrhosis and risk of digestive tract neoplasms. Ann Oncol 16 (2005), 1551–1555.
48. Zatonski, W.A., Sulkowska, U., Manczuk, M., Rehm, J., Boffetta, P., Lowenfels, A.B., et al. Liver cirrhosis mortality in Europe, with special attention to Central and Eastern Europe. Eur Addict Res 16 (2010), 193–201.
49. Bosetti, C., Levi, F., Lucchini, F., Zatonski, W.A., Negri, E., La Vecchia, C., Worldwide mortality from cirrhosis: an update to 2002. J Hepatol 46 (2007), 827–839.
50. Sangiovanni, A., Del Ninno, E., Fasani, P., De Fazio, C., Ronchi, G., Romeo, R., et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 126 (2004), 1005–1014.
51. Gallus, S., Lugo, A., Murisic, B., Bosetti, C., Boffetta, P., La Vecchia, C., Overweight and obesity in 16 European countries. Eur J Nutr 54 (2015), 679–689.
52. Deuffic-Burban, S., Deltenre, P., Buti, M., Stroffolini, T., Parkes, J., Muhlberger, N., et al. Predicted effects of treatment for HCV infection vary among European countries. Gastroenterology 143 (2012), 974–985, e914.
53. Lepage, C., Capocaccia, R., Hackl, M., Lemmens, V., Molina, E., Pierannunzio, D., et al. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: Results of EUROCARE-5. Eur J Cancer, 2015.
54. Liang, T.J., Ghany, M.G., Therapy of hepatitis C- back to the future. N Engl J Med 370 (2014), 2043–2047.